Pharmaceutical Technology

MARCH 10, 2023

Freeze-drying systems companies help in the verification and validation monitoring of the freeze-drying process to comply with the latest regulations and good automated manufacturing practice (GAMP) guidelines.

Manufacturing 147

Manufacturing Production Containment Antibody 147

The Pharma Data

JANUARY 5, 2021

ZFHN, an investor in local start-ups, is now providing up to EUR 60 million to help take CPV-101, a potentially game-changing complement regulator, to more advanced clinical stages. Complement regulators manage inflammatory processes by protecting the body’s own cells and preventing excessive inflammation. About Eleva.

Drugs 52

Drugs Business Development Regulation Antibody 52

pharmaphorum

DECEMBER 15, 2022

When capturing medical and field insights you have to comply with numerous regulations relevant to the world of data privacy – a challenge often compounded by the many different variables that govern the process of insight capture and analysis. Business Development Account Manager. Capturing Medical Insights With Zero-Risk.

Regulation 52

Regulation Compliance Pharma Companies Business Development 52

WCG Clinical

APRIL 3, 2023

Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote. Individual subscriptions , customized multi-user, and company licenses to FDAnews are also available. Learn more at fdanews.com.

Compliance 52

Compliance Drugs Manufacturing Regulation 52

pharmaphorum

MAY 5, 2022

With advances in rapid microbiological methods, revised industry regulation, enhanced knowledge of innovative therapies, and novel testing methods, this industry is ever expanding. Discuss expert guidance and explore the regulations concerning objectionable organisms in drug products. Event Hashtag: #PharmaMicroWC.

Contamination 52

Contamination Regulation Scientist Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 1, 2022

“For strip devices, you have just a few processes for the device assembly,” says Jean-François Bauer, head of marketing and business development at Mikron Automation. “In But in the highly regulated world of medical devices, there is no margin for error, and quality standards are consistently high.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

pharmaphorum

AUGUST 8, 2022

The boards of both companies have recommended the deal to shareholders, and the two companies suggested it should close before the end of the year – assuming of course it doesn’t fall foul of any antitrust issues raised by financial regulators. It comes shortly after the group closed a $6.7

Marketing 111

Marketing Sales Gene Editing Antibody 111

Drug Discovery World

JUNE 16, 2023

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. DDW’s Megan Thomas heard from attendees about key trends in the sector.

Manufacturing 52

Manufacturing In-Vivo Production Compliance 52

pharmaphorum

SEPTEMBER 18, 2020

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. .

Gene Editing 105

Gene Editing Gene Vaccination Vaccine 105

pharmaphorum

JANUARY 24, 2022

Engage with regulators about the guidance within machine learning and AI in Drug Discovery. CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President & Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms. Event Hashtag: #SMiAIDrugDis.

Drugs 52

Drugs Big Data Scientist Clinical Trials 52

pharmaphorum

NOVEMBER 4, 2022

There is also a narrowing of its therapeutic range – exiting fibrosis and kidney disease in favour of greater efforts in immunology and oncology – and an increase in business development deals to strengthen Galapagos’ pipeline that will be fuelled by healthy cash reserves of around €4.3 Jyseleca has made €60.5

Business Development 52

Business Development Sales Regulation Drugs 52

Drug Discovery World

JUNE 14, 2023

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. DDW’s Megan Thomas heard from attendees about key trends in the sector.

In-Vivo 52

In-Vivo Gene Manufacturing Development 52

Drug Discovery World

JUNE 12, 2023

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France from May 31 to June 3 2023.

Gene Therapy 52

Gene Therapy Manufacturing Gene Development 52

pharmaphorum

DECEMBER 7, 2020

Wokingham, United Kingdom — 7 December 2020 — PRISYM ID, a leading provider of regulated content and label management solutions for the life sciences sector, announced today that PRISYM 360 version 1.10 has achieved SAP® certification using SAP Cloud Platform Integration Suite. – Ends – About PRISYM ID.

Life Science 52

Life Science Compliance Clinical Trials Clinical Trials 52

pharmaphorum

JANUARY 14, 2021

However, the company’s head of strategic business development Parsi Parsinejad said that the system is differentiated from competitors by its focus on putting patients in control of their data. The new Seqster 7.1 Parsinejad told pharmaphorum in an interview: “You have been seeing a proliferation of cloud services.

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

Pharmaceutical Technology

OCTOBER 13, 2022

Businesses with highly effective software will be able to be able to provide the best customer service and flexible product offerings. According to Michael, legacy systems act as a barrier to business development and maintaining outdated technology becomes more expensive over time. Those with legacy systems will lag behind.

Production 130

Production Business Development Sales Regulation 130

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. However, NHP models cannot fully predict AAV transduction in the human liver. She received a Ph.D.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

Drug Discovery World

APRIL 17, 2024

Recently, research published by Dr Richard (Rick) Young (Whitehead Institute) describes the key mechanism of how these regRNAs regulate gene expression. So, regRNAs haven’t been exploited previously because scientists have only recently understood their role in regulating gene expression.

Gene Expression 59

Gene Expression Gene Genetic Disease RNA 59

pharmaphorum

OCTOBER 3, 2022

The way pharma is regulated based on compliance is a considerable barrier to allowing such a change, though. Gaurav Kapoor is co-founder of Indegene and heads the company’s co-commercialisation business while also driving new business development. ” About the interviewee.

Branding 116

Branding Doctors Doctor Compliance 116

Drug Discovery World

FEBRUARY 7, 2023

Lorenzo Bombardelli, a Business Developer and Scientist based in Amsterdam, posted on LinkedIn: “I was curious to see whether #AI monster #chatGPT could really replace 100s of study hours and years of work. It also suggests companies could use ChatGPT when putting together applications to regulatory agencies.

Drugs 52

Drugs Protein Regulation Research 52

pharmaphorum

AUGUST 24, 2020

With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech Forbius and its pipeline of drugs for cancer and fibrotic diseases.

Immune Response 59

Immune Response Antibody Drugs Licensing 59

Drug Discovery World

JANUARY 30, 2024

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

The Pharma Data

DECEMBER 17, 2020

SpringWorks Therapeutics — Badreddin Edris has been promoted from chief business officer to COO and Mary Smith, Mary Smith, currently senior vice president of Clinical Research and Development, has been promoted to chief development officer at SpringWorks. Immune Regulation – U.K.-based based Immune Regulation Ltd.

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

FEBRUARY 11, 2021

In each location these regulations and codes of conduct present challenges and opportunities for companies when working together with patients as collaborators in the design and conduct of trials. Linking pharma with patients.

Clinical Trials 94

Clinical Trials Clinical Trials Trials Clinical Research 94

Find Me Cure

APRIL 23, 2020

Firstly, even though scientists are busy developing a vaccine, one is not expected earlier than 2021. This means that in order for herd immunity to work, 50-70% of the world population needs to get infected and then develop antibodies. . In the case of the coronavirus, however, there are too many unknowns.

Immune Response 117

Immune Response Antibody Scientist Development 117

The Pharma Data

JANUARY 12, 2021

As part of this role he built innovative, high-performing development teams and managed the Regeneron’s regulatory filings, interactions with regulatory agencies, product launches, and business development and licensing activities across its product portfolio. About Tiziana Life Sciences.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

OCTOBER 1, 2021

Merck referred to as MSD outside the us and Canada, and Acceleron Pharma Inc, a publicly traded biopharmaceutical company, today announced that the businesses have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Acceleron for $180 per share in cash for an approximate total equity value of $11.5

Protein 52

Protein Development Trials Research 52

The Pharma Data

OCTOBER 27, 2020

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES : Doreen McMorran: doreen@ovationscience.com Phone: 604-283-0903 ext.

Sales 52

Sales Production Drug Delivery Development 52

pharmaphorum

JANUARY 26, 2021

This trend can be seen as a net positive, in that it will enable digital therapeutic solution developers to concentrate on building the individual vertical products that will live on these platforms.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. Business Development/Other Developments. In the second quarter of 2021, the company recognized acquired in-process research and development charges of $25.0

Antibody 52

Antibody Sales Development Production 52

The Pharma Data

JANUARY 4, 2021

relevant government policies and regulations relating to our industry. relevant government policies and regulations relating to our industry.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

XTalks

APRIL 21, 2023

Life science startups face unique challenges given the highly regulated and complex nature of the industry. Here are some lessons that entrepreneurs in this space can learn from past successes and failures: Prioritize ethics and integrity: The Theranos case highlights the importance of maintaining ethical standards in business.

Life Science 98

Life Science Trials Production Compliance 98

The Pharma Data

OCTOBER 14, 2020

and foreign tax laws or the impact of disputes with governmental tax authorities; and the impact of Irish laws.

Production 40

Production Branding Development Regulation 40

The Pharma Data

JANUARY 6, 2021

and foreign government regulation in the manufacture of pharmaceutical products, including U.S. our expectations regarding our ability to obtain and maintain sufficient intellectual property protection for our products; our ability to comply with stringent U.S.

Production 52

Production Marketing Containment Sales 52

Drug Discovery World

MAY 16, 2023

Lentiviral vectors demand Naiara Tejados, Head of Marketing and Technology Development at VIVEbiotech & Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, anticipate that 2023 will be a very good year for VIVEbiotech, due to the increasing demand for lentiviral vectors.

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

The Pharma Data

AUGUST 3, 2021

Research & Development (R&D) expenses increased 12% primarily due to higher research and early pipeline spend and late-stage development program spend, including our recent business development activities. Acquired IPR&D expenses in 2021 were driven by the Five Prime Therapeutics acquisition. Bemarituzumab.

Sales 52

Sales Production Antibody Development 52

Drug Discovery World

JUNE 13, 2023

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. DDW’s Megan Thomas heard from attendees about key trends in the sector.

Manufacturing 98

Manufacturing Production Gene Clinical Trials 98